Zimbabwe - World Food Programme Feeds 2 Million In October But Forced To Cut Rations In November

WFP distributed 29,000 tons of food to around 2 million vulnerable people across Zimbabwe in October - the first month of large-scale distributions.
The 2 million beneficiaries breakdown as follows:

Tags: beneficiaries, beneficiary, cereal, cereals, distributions, donations, food basket, food commodities, food crisis, pipeline, rations, rural and urban areas, rural areas, [...]

Trials Terminated Due To Poor Enrollment Are Four Times More Likely To Involve A Marketed Therapy Versus A Novel Drug

Trial termination is a natural consequence of clinical development, with the largest numbers of trial terminations occuring at Phase II. In the November issue of Good Clinical Practice Journal (GCPj) , Citeline authors Christine Blazynski and Tracy DeGregorio analyzed terminated Phase II trials in oncology - with specific attention to trials involving solid tumors [...]

Bionovo’s VG101 Shows Greater Efficacy Than Estrogen In The Treatment Of Vaginal Dryness

Bionovo, Inc. (Nasdaq: BNVI) will present an abstract in a presentation on their new drug candidate, VG101, for the treatment of vaginal dryness, at the 19th Annual Meeting of the North American Menopause Society in Orlando, Florida on September 26, 2008. Dr. Mary Tagliaferri, president and chief medical officer [...]

Concert Pharmaceuticals Initiates CTP-347 Phase I Clinical Trial - Potential Best-in-Class Non-Hormonal Treatment For Vasomotor Symptoms

Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase I study in healthy volunteers to evaluate the safety, tolerability and pharmacokinetics of CTP-347, a novel deuterium-containing serotonin modulator created by Concert researchers. Concert intends to evaluate CTP-347 as a non-hormonal treatment for vasomotor symptoms (VMS or hot flashes) in patients with increased risk [...]

Concert Pharmaceuticals Presents Preclinical Results Supporting Co-Administration Of CTP-347 And Tamoxifen

Concert Pharmaceuticals, Inc. announced today the presentation of data from a preclinical study demonstrating the potential of CTP-347, its novel deuterium-containing serotonin modulator, to avoid the risk of adverse drug-drug interactions when co-administered with tamoxifen, a widely-used breast cancer drug. These data were the subject of a poster presentation at the North American Menopause Society’s [...]